Science China-Life Sciences

Two major revisions and one minor revision, a total of seven months from start to finish, with four reviewers providing highly professional feedback. The editorial department handled the process quickly, returning reviewer feedback within three weeks each time. Due to the impact of the pandemic, the progress of the experiment was not good, so it took a long time. The official acceptance rate of this journal is only 17%, and the number of published articles is very small. I hope that its international influence can be further enhanced in the future. Below are the processing stages of my article:

- Awaiting ED Assignment: 2021-07-30
- Awaiting Reviewer Scores: 2021-07-31
- Awaiting VEIC Decision: 2021-08-19
- Major revision: 2021-08-21
- Awaiting Reviewer Scores: 2021-11-19
- Awaiting VEIC Decision: 2021-12-3
- Major revision: 2021-12-5
- Awaiting ED Processing: 2022-2-15
- Minor revision: 2022-2-17
- Awaiting ED Processing: 2022-2-19
- Accept: 2022-2-22

The quality and level of articles in the journal have been steadily increasing in the past two years. Many experts from the Chinese Academy of Sciences and top universities have recently submitted excellent articles, hoping to be on par with Cell Research.